Page last updated: 2024-09-03
l 158809 and glyburide
l 158809 has been researched along with glyburide in 2 studies
Compound Research Comparison
| Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) | Studies (glyburide) | Trials (glyburide) | Recent Studies (post-2010) (glyburide) |
|---|---|---|---|---|---|
| 137 | 0 | 7 | 6,554 | 620 | 1,344 |
Protein Interaction Comparison
| Protein | Taxonomy | l 158809 (IC50) | glyburide (IC50) |
|---|---|---|---|
| ATP-binding cassette sub-family C member 9 | Homo sapiens (human) | 0.22 | |
| Bile salt export pump | Rattus norvegicus (Norway rat) | 5.7 | |
| Bile salt export pump | Homo sapiens (human) | 5.5333 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 1.602 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.0043 | |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.1121 | |
| NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | 10 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.8 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cheng, DY; Feng, CJ; Kadowitz, PJ; Kaye, AD; Nossaman, BD | 1 |
| Egashira, K; Shimokawa, H; Tada, H; Takemoto, M; Takeshita, A; Ueno, H; Yamamoto, M | 1 |
Other Studies
2 other study(ies) available for l 158809 and glyburide
| Article | Year |
|---|---|
Influence of N omega-nitro-L-arginine methyl ester, LY83583, glybenclamide and L158809 on pulmonary circulation.
Topics: Aminoquinolines; Angiotensin Receptor Antagonists; Animals; Arginine; Drug Interactions; Glyburide; Hypoxia; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasoconstriction | 1994 |
Glibenclamide, a specific inhibitor of ATP-sensitive K+ channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Coronary Circulation; Coronary Vessels; Dogs; Enzyme Inhibitors; Glyburide; Hypoglycemic Agents; Imidazoles; NG-Nitroarginine Methyl Ester; Potassium Channel Blockers; Pyridines; Tetrazoles; Vasodilation | 1997 |